Get updated: Latest ATS/ISDA guidelines for pneumonia
July 20, 2020
This session will cover the new ATS/IDSA guidelines for CAP, which will include what initial testing to order, which empiric antibiotics to use, and how to manage patients at risk for resistant organisms.
Sepsis: Vitamin C, thiamine, glucocorticoids remain controversial
July 20, 2020
Hospitalists are traditionally well versed in current sepsis guidelines, but time to treatment is paramount, and it can be difficult to stay up to date on the latest studies in the field.
Cushing’s and COVID-19: Nontraditional symptoms keys to assessment, treatments
July 2, 2020
Features of Cushing’s syndrome may confound diagnosis and treatment of COVID-19, and also could make patients more susceptible to the pandemic.
WHO clarifies comments on asymptomatic transmission of SARS-CoV-2
June 10, 2020
Dr. Maria Van Kerkhove said she wasn’t stating a WHO policy when she characterized asymptomatic transmission as rare.
Latest data on COVID-19 patients with rheumatic diseases revealed in registry
April 23, 2020
Data for a total of 583 COVID-19 patients have now been made available.
Researchers investigate impact of smoking on COVID-19 risk
April 20, 2020
Early reports from China showed a case fatality rate of 4.7% for men, compared with 2.8% for women.
The wide-ranging impact of hospital closures
April 10, 2020
It is not unusual for hospitalists to step up during a hospital closure and advocate for their patients on behalf of the community.
Opioids, benzodiazepines carry greater risk of COPD-related hospitalization
October 25, 2019
The risk of hospitalization because of respiratory events for patients with COPD was especially high when opioid and benzodiazepine medications were combined.
Study: Cardiac biomarkers predicted CV events in CAP
August 13, 2019
The results suggest a change in usual practice is needed to reduce cardiovascular community-acquired pneumonia complications, according to a study author.
Sepsis survivors’ persistent immunosuppression raises mortality risk
August 7, 2019
Individuals with persistent biomarkers of inflammation and immunosuppression had a higher risk of readmission and death because of cardiovascular disease.